ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -18.5% | -3.4% | -24.5% | -18.4% | -21.4% | -65.9% | -16.8% | +0.8% | – | – | +645.5% | |
| – | -18.5% | -3.1% | -25.0% | -18.7% | -21.6% | -68.2% | -15.9% | +4.6% | – | – | +728.2% | |
| – | -19.2% | -5.9% | -24.3% | -18.1% | -21.6% | -73.5% | -12.1% | +10.0% | – | – | +873.8% | |
| – | -19.2% | -5.9% | -24.3% | -18.1% | -21.6% | -73.5% | -12.1% | +10.0% | – | – | +873.8% | |
| – | +1.7% | +40.3% | -2.5% | +2.4% | -0.2% | -26.1% | +4.7% | +6.1% | – | – | +5.5% | |
| – | +4.7% | +92.6% | +1.7% | +11.2% | +6.5% | -15.7% | +9.2% | +10.4% | – | – | +5.5% | |
| – | -1.5% | -1.5% | +179.9% | +78.2% | +45.4% | -53.0% | +25.6% | +13.2% | – | – | – | |
| – | -45.0% | +110.5% | -33.4% | -17.5% | +89.3% | -19.4% | +28.2% | +0.4% | – | – | +0.0% | |
| – | -32.2% | -47.8% | -84.5% | -374.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.3% | +0.0% | +0.0% | 0.0% | +0.0% | +2.1% | +24.2% | +38.5% | +1,167.0% | +54.9% |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.